• Transforming the Treatment of Chronic Disease Through Science, Digital Engagement, and Proven Outcomes

    Transforming the Treatment of Chronic Disease Through Science, Digital Engagement, and Proven Outcomes

  • NEBGH President & CEO Laurel Pickering to Join WellDoc as Chief Revenue Officer

    NEBGH President & CEO Laurel Pickering to Join WellDoc as Chief Revenue Officer

  • BlueStar Clinically Proven to Reduce A1C by 1.7 to 2.0 Points

    BlueStar Clinically Proven to Reduce A1C by 1.7 to 2.0 Points

  • American Journal of Managed Care Discusses WellDoc / AADE Partnership

    American Journal of Managed Care Discusses WellDoc / AADE Partnership

  • WellDoc’s Janice MacLeod Authors Journal of Academy of Nutrition and Dietetics Article

    WellDoc’s Janice MacLeod Authors Journal of Academy of Nutrition and Dietetics Article

  • Meet WellDoc’s Expert Clinical Team

    Meet WellDoc’s Expert Clinical Team

See Why We’re a Leader in Digital Therapeutics and Type 2 Diabetes Self-care

Our Suite of Products

Our digital health solutions are changing the face of chronic disease management, reducing costs, improving clinical outcomes, and creating hope and change for individuals living with chronic diseases.

While our current solution, BlueStar, is a robust, highly intelligent app focused on type 2 diabetes, we are also pursuing digital solutions in other therapeutic areas.

BlueStar

BlueStar

Designed with clinical outcomes in mind

BlueStar Rx

BlueStar Rx

Includes insulin bolus dose calculator and requires Rx

BlueStar C

BlueStar C

More focused on tracking and sharing data

Strategic Partners

Clinical Evidence

Clinical Evidence

Our clinical evidence shows a mean reduction of 1.7 to 2.0 point A1C drop for individuals living with type 2 diabetes who used BlueStar.

Read More About Us

  • Forbes Disruptive Innovation Article
  • JAMA mHealth Coverage
  • Nature Biotechnology mHealth Coverage
  • JMIR mHealth Coverage

Digital Health Company of Firsts

WellDoc created digital health solutions long before smart phones were invented. We are the first digital health company to conduct randomized clinical trials that demonstrated significant clinical outcomes, which were published in peer-reviewed journals, and the first digital health company built on a life science business model.